Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.2390
+0.0190 (8.64%)
At close: Sep 10, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €4.4 million as of September 11, 2026. Its market cap has decreased by -42.22% in one year.
Market Cap
4.40M
Enterprise Value
8.67M
Revenue
1.81M
Ranking
n/a
PE Ratio
0.77
Stock Price
€0.24
ChartMarket Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has decreased from 5.82M to 4.40M, a decrease of -24.48%. That is a compound annual growth rate of -6.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 4.40M | -41.09% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 23.05M |
| Aelis Farma | 13.79M |
| Advicenne | 12.85M |
| Aton | 11.76M |
| NFL Biosciences | 10.90M |
| TME Pharma | 10.11M |
| Poxel | 9.94M |
| Biophytis | 6.12M |